Skip to main content
Clinical Trials/NCT06520267
NCT06520267
Completed
Not Applicable

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Patients With Symptomatic Benign Prostatic Hyperplasia: a Prospective Observational Study

Tribhuvan University Teaching Hospital, Institute Of Medicine.1 site in 1 country131 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Antibiotic therapy
Conditions
Bacteriuria in Symptomatic Benign Prostate Hyperplasia
Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Enrollment
131
Locations
1
Primary Endpoint
Identification of common pathogens and Antibiotic susceptibility testing
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this prospective observational study is to identify the common pathogens and antibiotic sensitivity pattern in urine samples of men with symptomatic BPH and to assess severity of LUTS in patients with symptomatic BPH using IPSS score before and after antibiotic therapy.

Detailed Description

This was a hospital-based prospective observational study. All patients with symptomatic BPH attending the Urology Out-Patient Department (OPD) of the study site were enrolled. Informed and written consent was obtained from all participants. Demographic data were recorded, and detailed histories were taken regarding the duration and symptoms of BPH, including incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining, nocturia, and relevant past history. IPSS scoring was conducted. A thorough clinical examination, including general physical, systemic, and digital rectal examination, was performed. During the rectal examination, the prostate was checked for nodules, softness, induration, or tenderness. Urine culture and antibiotic sensitivity tests were conducted to assess the bacteriological profile.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
August 15, 2021
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Responsible Party
Principal Investigator
Principal Investigator

Ishwor Thapaliya

Prinicpal Investigator

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic BPH.

Exclusion Criteria

  • Patients with indwelling catheters
  • Recent antibiotic use
  • Immunocompromised states (e.g., HIV, HCV)
  • Uncontrolled diabetes mellitus (Hemoglobin A1c \> 7%)
  • Steroid therapy
  • Those who declined to provide consent

Arms & Interventions

symptomatic BPH

All patients with symptomatic BPH attending the Urology Out-Patient Department (OPD) of the study site were enrolled. Informed and written consent was obtained from all participants. Demographic data were recorded, and detailed histories were taken regarding the duration and symptoms of BPH and relevant past history. IPSS scoring was conducted. A thorough clinical examination, including general physical, systemic, and digital rectal examination, was performed. During the rectal examination, the prostate was checked for nodules, softness, induration, or tenderness. Urine culture and antibiotic sensitivity tests were conducted to assess the bacteriological profile.

Intervention: Antibiotic therapy

Outcomes

Primary Outcomes

Identification of common pathogens and Antibiotic susceptibility testing

Time Frame: 4 weeks

Urine culture and antibiotic sensitivity tests were conducted to assess the bacteriological profile among symptomatic patients with BPH.

Secondary Outcomes

  • Severity of LUTS in patients with symptomatic BPH(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials